Failure to detect colonic mucosal hyperproliferation in mutation positive members of a family with hereditary non-polyposis colorectal cancer

Histopathology

Volumn 30, Issue 3, 1997, Pages 201-207

  Jass, J R ^a,d   Ajioka, Y ^b   Radojkovic, M ^c   Allison, L J ^a   Lane, M R ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NIIGATA UNIVERSITY   (Japan)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

colon; hereditary cancer; proliferation kinetics

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67;

ADULT; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; COLON BIOPSY; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

EID: 0030928527     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1997.d01-589.x     Document Type: Article

References (42)

1. Risio M. Cell proliferation of colorectal tumor progression: an immunohistochemical approach to intermediate biomarkers. J. Cell. Biochem. 1992: 16; 79-87.
2. Lipkin M. Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in disease leading to colonic cancer. Cancer 1974: 54; 878-888.
3. Deschner EE, Lipkin M. Proliferative patterns in colonic mucosa in familial polyposis. Cancer 1975: 35; 413-418.
4. Deschner EE, Raicht RE. Kinetic and morphologic alterations in the colon of a patient with multiple polyposis. Cancer 1981: 47; 2440-2445.
5. Cats A, Kleibeuker JH. Kuipers F et al. Changes in rectal epithelial cell proliferation and intestinal bile acids after subtotal colectomy in familial adenomatous polyposis. Cancer Res. 1992: 52; 3552-3557.
6. Potten CS, Kellett M, Rew DA, Roberts SA. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites. proximity to a tumour. and polyposis coli. Gut 1992: 33; 524-529.
7. Wong AJ, Kohn GJ, Schwartz HJ, Ruebner BH, Lawson MJ. Colorectal cancer and noncancer patients have similar labeling indices by microscopy and computed image analysis. Hum. Pathol. 1995: 26; 1329-1332.
8. Terpstra OT, Van Blankenstein M, Dees J, Eilers GAM. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987: 92; 704-708.
9. Cats A, de Vries GE, Kleibeuker JH. Proliferation rate in hereditary non polyposis colorectal cancer. J. Natl. Cancer Inst. 1991: 83; 1687-1688.
10. Lynch PM, Wargovich MJ, Lynch HT et al. A follow-up study of colonic epithelial proliferation as a biomarker in a native-American family with hereditary non-polyposis colorectal cancer. J. Natl. Cancer Inst. 1991: 83; 951-954.
11. Takahashi H, Oishi Y, Chuang S-S, Morii S. Effects of tissue fixation and processing on proliferating cell nuclear antigen (PCNA) immunohistochemistry. Acta Pathol. Jpn 1992: 42; 621-623.
12. Van de Water NS, Jeevaratnam P, Browett PJ, Stewart SM, Lane MR, Jass JR. Direct mutational analysis in a family with hereditary non-polyposis colorectal cancer. Aust. N. Z. J. Med. 1994: 24; 682-686.
13. British Standard Institution. Precision of test methods 1 : Guide for the determination and reproducibility for a standard test method (BS 5497, part 1). London: BSI, 1979.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986: i; 307-310.
15. Lynch HT, Drouhard T, Vasen HFA et al. Genetic counseling in a Navajo hereditary nonpolyposis colorectal cancer kindred. Cancer 1996: 77; 30-35.
16. Mills SJ, Shepherd NA, Hall PA, Hastings A, Mathers JC, Gunn A. Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. Gut 1995: 56; 391-394.
17. Otori K, Sugiyama K, Hasebe T, Fukushima S, Esumi H. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res. 1995: 55; 4743-4746.
18. Nakamura S, Kino L, Baba S. Nuclear DNA content of isolated crypts of background colonic mucosa from patients with familial adenomatous polyposis and sporadic colorectal cancer. Gut 1993: 34; 1240-1244.
19. Thomas MG, Tebbutt S, Williamson RCN. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 1992: 33; 1660-1663.
20. Yoshikawa R, Utsunomiya J. Cell proliferation kinetics are abnormal in transitional mucosa adjacent to colorectal carcinoma. Br. J. Surg. 1996: 83; 36-39.
21. Levy DB, Smith KJ, Beazebarclay Y, Hamilton SR, Vogelstein B, Kinzler KW. Inactivation of both APC alleles in human and mouse tumors. Cancer Res. 1994: 54; 5953-5958.
22. Bleiberg H, Buyse M, Galand P. Cell kinetic indicators of premalignant stages of colorectal cancer. Cancer 1985: 56; 124-129.
23. Ikeda N, Mizuno M, Okada H, Tomoda J, Tsuji T. Immunohistochemical analysis of epithelial cell proliferation in normal-appearing rectal mucosa of patients with colorectal adenoma and cancer using an in vitro labeling method with bromodeoxyuridine. Acta Med. Okayama 1994: 48; 243-247.
24. van't Hof A, Gilissen K. Cohen RJ et al. Colonic cell proliferation in two different ethnic groups with contrasting incidence of colon cancer: is there a difference in carcinogenesis? Gut 1995: 36; 691-695.
25. Anti M, Marra G, Armelao F et al. Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut 1993: 34; 535-530.
26. Rooney PS, Clarke PA, Gifford KA, Hardcastle JD, Armitage NC. The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR). Br. J. Cancer 1993: 68; 172-175.
27. Anti M, Marra G, Percesepe A, Armelao F, Gasbarrini G. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer. J. Cell Biochem. 1994: Suppl: 19; 68-75.
28. Paganelli GM, Biasco G. Santucci R et al. Rectal cell proliferation and colorectal cancer risk level in patients with nonfamilial adenomatous polyps of the large bowel. Cancer 1991: 68; 2451-2454.
29. Nakamura S, Goto J, Kitayama Y, Sheffield JP, Talbot IC. Flow cytometric analysis of DNA synthetic phase fraction of the normal appearing colonic mucosa in patients with colorectal neoplasms. Gut 1995: 37; 398-401.
30. Kashtan H, Gregoire RC, Hay K, Stern HS. Colonic epithelial proliferation indices before and after colon cancer removal. Cancer Invest. 1993: 11; 113-117.
31. Kubben FJGM, Peeters-Haesevoets A, Engels LGJB et al. Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut 1994: 35; 530-535.
32. Roncucci L, Ponz de Leong M. Scalmati A et al. The influence of age on colonic epithelial cell proliferation. Cancer 1988: 62; 2373-2377.
33. Weisgerber UM, Boeing H, Owen RW, Waldherr R, Raedsch R, Wahrendorf J. Effect of long term placebo controlled calcium supplementation on sigmoidal cell proliferation in patients with sporadic adenomatous polyps. Gut 1996: 38; 396-402.
34. Barsoum GH, Thompson H, Neoptolemos JP, Keighley MRB. Dietary calcium does not reduce experimental colorectal carcinogenesis after small bowel resection despite reducing cellular proliferation. Gut 1992: 33; 1515-1520.
35. Marra G, Anti M, Percesepe A et al. Circadian variations of epithelial cell proliferation in human rectal crypts. Gastroenterology 1994; 106; 982-987.
36. Macrae FA, Kilias D, Sharpe K, Hughes N, Young GP, Maclennan R. Rectal epithelial cell proliferation: comparison of errors of measurement with inter-subject variance. J. Cell Biochem. 1994: suppl. 19; 84-90.
37. Rooney PS, Robinson MHE, Clarke PA, Hardcastle JD, Armitage NC. Individuals with a strong family history of colorectal cancer demonstrate abnormal rectal mucosal proliferation. Br J. Surg. 1993: 80; 249-251.
38. Patchett SE, Saunders BP, Harocopos C, Hodgson SV, Alstead EM, Farthing MJG. Regional proliferative patterns in the colon of patients at risk of hereditary non polyposis colon cancer (HNPCC). Gut 1993: 34; S53.
39. Diebold J, Lai MD, Lohrs U. Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Virchows Arch. B 1992: 62; 283-289.
40. Jass JR. Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer. Histopathology 1995: 27; 263-267.
41. Jass JR, Edgar S. Unicryptal loss of heterozygosity in hereditary non-polyposis colorectal cancer. Pathology 1994: 26; 414-417.
42. Williams GT, Geraghty JM, Campbell F, Appleton MAC, Williams ED. Normal colonic mucosa in hereditary non-polyposis colorectal cancer shows no generalised increase in somatic mutation. Br. J. Cancer 1995: 71; 1077-1080.